Evidence map›Paper›PMID 39063762›Full record

ArticleMaterials (Basel, Switzerland)2024

Fabrication and Characterization of Biomedical Ti-Mg Composites via Spark Plasma Sintering.

Taisei Masuda, Minho Oh, Equo Kobayashi

Abstract read
In one paragraph

Article in Materials (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Taisei MasudaDepartment of Materials Science and Engineering, School of Materials and Chemical Technology, Tokyo Institute of Technology, S8-18, 2-12-1 Ookayama, Meguro-ku, Tokyo 152-8552, Japan.
Minho OhDepartment of Materials Science and Engineering, School of Materials and Chemical Technology, Tokyo Institute of Technology, S8-18, 2-12-1 Ookayama, Meguro-ku, Tokyo 152-8552, Japan.ORCID 0000-0003-0635-163X
Equo KobayashiDepartment of Materials Science and Engineering, School of Materials and Chemical Technology, Tokyo Institute of Technology, S8-18, 2-12-1 Ookayama, Meguro-ku, Tokyo 152-8552, Japan.ORCID 0000-0001-8043-5044

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The fabrication of Ti-Mg composite biomaterials was investigated using spark plasma sintering (SPS) with varying Mg contents and sintering pressures. The effects of powder mixing, Mg addition, and sintering pressure on the microstructure and mechanical properties of the composite materials were systematically analyzed. Uniform dispersion of Mg within the Ti matrix was achieved, confirming the efficacy of ethanol-assisted ball milling for consistent mixing. The Young's modulus of the composite materials exhibited a linear decrease with increasing Mg content, with Ti-30vol%Mg and Ti-50vol%Mg demonstrating reduced modulus values compared to pure Ti. Based on density measurements, compression tests, and Young's modulus results, it was determined that the sinterability of Ti-30vol%Mg saturates at a sintering pressure of approximately 50 MPa. Moreover, our immersion tests in physiological saline underscore the profound significance of our findings. Ti-30vol%Mg maintained compressive strength above that of cortical bone for 6-to-10 days, with mechanical integrity improving under higher sintering pressures. These findings mark a significant leap towards the development of Ti-Mg composite biomaterials with tailored mechanical properties, thereby enhancing biocompatibility and osseointegration for a wide range of biomedical applications.

Indexed as

biomaterialsspark plasma sinteringstress shieldingTi-Mg compositesYoung’s modulus

Identifiers

PMID39063762
PMCPMC11278337

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.